CompanyGraph
What stands out
- Earnings significantly exceed cash generation
- Valued far above the size of its business
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleMarket cap is $2.48B, above the global median of $1.15B
- FinancialsAltman Z-Score 3.91: safe zone
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Earnings significantly exceed cash generation
- Valued far above the size of its business
Financials view
Market Capitalization
16.73BCNY2.48B · vs all stocks (USD)
Trailing P/E
84.16xRevenue (TTM)
940.78MCNY139.72M · vs all stocks (USD)
Profit Margin
21.26%Beta
0.7730xvs all stocks
52-Week Change
-46.89%vs all stocks
Market Capitalization
16.73BCNY2.48B · vs all stocks (USD)
Enterprise Value
17.33BCNY2.57B · vs all stocks (USD)
Trailing P/E
84.16xForward P/E
56.11xPrice to Sales (TTM)
17.78xPrice to Book (MRQ)
8.58xEnterprise to Revenue
18.42xEnterprise to EBITDA
-159.84xGross Margin
66.08%Profit Margin
21.26%Operating Margin
6.12%Return on Assets (TTM)
-3.80%Return on Equity (TTM)
9.73%Revenue (TTM)
940.78MCNY139.72M · vs all stocks (USD)
Revenue per Share (TTM)
2.08CNYUpdated Aug 20, 2026Quarterly Revenue Growth
2.30%Gross Profit (TTM)
540.08MCNY80.21M · vs all stocks (USD)
EBITDA (TTM)
-108.40MCNY-16.10M · vs all stocks (USD)
Net Income (TTM)
199.99MCNY29.70M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
950.30%Operating Cash Flow (TTM)
26.38MCNY3.92M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
431.08MCNY64.02M · vs all stocks (USD)
5-Year Average Dividend Yield
0.68%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
37.34MCNYFY2025 · Dec 31, 2025Revenue
932.27MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
405.76MCNYFY2025 · Dec 31, 2025Gross Profit
526.52MCNYFY2025 · Dec 31, 2025Operating Income
-250.16MCNY-37.15M · vs all stocks (USD)
Pre-tax Income
-369.45MCNYFY2025 · Dec 31, 2025Income Tax Expense
-22.99MCNYFY2025 · Dec 31, 2025Net Income
-346.46MCNYFY2025 · Dec 31, 2025EBIT
-311.66MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
-54.70MCNYFY2025 · Dec 31, 2025Research & Development
157.25MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
361.44MCNYFY2025 · Dec 31, 2025Other Operating Expenses
18.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.35MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
57.79MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.7478CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.7478CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
451.72MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
451.72MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-346.46MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
8.66MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-142.94MCNYFY2025 · Dec 31, 2025Free Cash Flow
-267.71MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
497.38MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-346.46MCNYFY2025 · Dec 31, 2025Other Non-cash Items
75.47MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
89.69MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
38.35MCNYFY2025 · Dec 31, 2025Capital Expenditures
-124.77MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.04BCNYFY2025 · Dec 31, 2025Sale of Investments
2.06BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-105.21MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.11BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.66BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-56.84MCNYFY2025 · Dec 31, 2025Other Financing Charges
-234.78MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
157.27MCNYFY2025 · Dec 31, 2025Shares Outstanding
451.69MSharesUpdated Aug 20, 2026Float Shares
160.07MSharesUpdated Aug 20, 2026% Held by Insiders
68.16%vs all stocks
% Held by Institutions
3.27%vs all stocks
Total Cash (MRQ)
1.40BCNY208.14M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.13CNYUpdated Aug 20, 2026Total Debt (MRQ)
2.08BCNY309.56M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.06xCurrent Ratio (MRQ)
1.45xBook Value per Share (MRQ)
4.32CNYUpdated Aug 20, 2026Total Assets
4.04BCNY600.35M · vs all stocks (USD)
Total Current Assets
1.10BCNYFY2025 · Dec 31, 2025Total Liabilities
2.64BCNYFY2025 · Dec 31, 2025Total Non-current Assets
2.94BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
1.50BCNYFY2025 · Dec 31, 2025Total Current Liabilities
1.14BCNYFY2025 · Dec 31, 2025Cash
509.06MCNYFY2025 · Dec 31, 2025Cash Equivalents
6.32MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
515.38MCNYFY2025 · Dec 31, 2025Accounts Receivable
205.33MCNYFY2025 · Dec 31, 2025Inventory
215.91MCNYFY2025 · Dec 31, 2025Accounts Payable
82.04MCNYFY2025 · Dec 31, 2025Short-term Debt
703.21MCNYFY2025 · Dec 31, 2025Other Current Liabilities
6.82MCNYFY2025 · Dec 31, 2025Long-term Debt
1.37BCNYFY2025 · Dec 31, 2025Common Stock (Book)
451.69MCNYFY2025 · Dec 31, 2025Retained Earnings
389.67MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.41BCNY208.92M · vs all stocks (USD)
Treasury Stock
139.63MCNYFY2025 · Dec 31, 202552-Week Low
29.31CNYUpdated Aug 20, 202652-Week High
76.88CNYUpdated Aug 20, 202652-Week Change
-46.89%vs all stocks
Beta
0.7730xvs all stocks
50-Day MA
36.67CNYUpdated Aug 20, 2026200-Day MA
37.81CNYUpdated Aug 20, 2026Avg 10-Day Volume
14.55MSharesUpdated Aug 20, 2026Avg 30-Day Volume
14.09MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.4400CNYUpdated Aug 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Earnings significantly exceed cash generationSignificant
Net Income (USD, TTM): 29,702,909.269Operating Cash Flow (USD, TTM): 3,918,328.9
Valued far above the size of its businessSignificant
Price-to-Sales: 17.78Revenue Growth YoY: 0.02
Financial Health
Altman Z-Score 3.91: safe zoneNotable
Altman Z-Score: 3.91
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Market cap is $2.48B, above the global median of $1.15BNotable
Market cap (USD): 2,484,172,650.594Global Median: 1,146,734,693.424
Levered free cash flow is $64.02M, above the global median of $16.24MNotable
Levered free cash flow (USD): 64,023,782.979Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Curaleaf Holdings, Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Regencell Bioscience Holdings Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tonghua Dongbao Pharmaceutical Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRule
China Resources Double Crane Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
HUTCHMED
Tier 1ProductionApproval-Gated PipelineRule
Pharvaris N.V.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Immunome Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shandong Buchang Pharmaceuticals Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
GN Store Nord A/S
Tier 1ProductionApproval-Gated PipelineRuleFlow
TransMedics Group Inc.
Tier 1ProductionApproval-Gated PipelineFlowRule